Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy

Adam C. Berger, Aaron Bloomenthal, Benny Weksler, Nathaniel Evans, Karen A. Chojnacki, Charles J. Yeo, Ernest L. Rosato

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Major morbidity and mortality rates continue to be high in large series of transthoracic esophagectomies. Minimally invasive approaches are being increasingly used. We compare our growing series of minimally invasive (combined thoracoscopic and laparoscopic) esophagectomies (MIEs) with a series of open transthoracic esophagectomies. Study Design: We identified 65 patients who underwent an MIE with thoracoscopy/laparotomy (n = 11), Ivor Lewis (n = 2), or 3-hole approach (n = 52). These patients were compared with 53 patients who underwent open Ivor-Lewis esophagectomy (n = 15) or 3-hole esophagectomy (n = 38) over the past 10 years. Results: The MIE and open groups were similar regarding gender and average age. The majority of patients in the open group underwent neoadjuvant chemoradiation therapy (81%); a significantly smaller (43%) number of patients in the MIE group underwent neoadjuvant therapy (p < 0.0001). Regarding oncologic efficacy, 97% and 94% of patients in both groups underwent R0 resections. Patients undergoing MIE had a significant increase in the number of harvested lymph nodes (median 20 vs 9; p < 0.0001). Length of stay was significantly decreased in patients who underwent MIE (8.5 days vs 16 days; p = 0.002). Finally, there were significantly fewer serious complications (grades 3-5) in the MIE group (19% vs 48%; p = 0.0008). Conclusions: In this initial report of a single-institution series of MIE, we demonstrate that oncologic efficacy is not compromised and may actually be improved with a significantly increased number of harvested LNs. We also demonstrate that this approach is associated with fewer serious complications and a significant decrease in the length of postoperative hospital stay.

Original languageEnglish (US)
Pages (from-to)560-566
Number of pages7
JournalJournal of the American College of Surgeons
Volume212
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Esophagectomy
Neoadjuvant Therapy
Length of Stay
Thoracoscopy
Laparotomy
Lymph Nodes
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. / Berger, Adam C.; Bloomenthal, Aaron; Weksler, Benny; Evans, Nathaniel; Chojnacki, Karen A.; Yeo, Charles J.; Rosato, Ernest L.

In: Journal of the American College of Surgeons, Vol. 212, No. 4, 01.04.2011, p. 560-566.

Research output: Contribution to journalArticle

Berger, Adam C. ; Bloomenthal, Aaron ; Weksler, Benny ; Evans, Nathaniel ; Chojnacki, Karen A. ; Yeo, Charles J. ; Rosato, Ernest L. / Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. In: Journal of the American College of Surgeons. 2011 ; Vol. 212, No. 4. pp. 560-566.
@article{919bedbf2b5a4748aeded0eb40af26a2,
title = "Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy",
abstract = "Background: Major morbidity and mortality rates continue to be high in large series of transthoracic esophagectomies. Minimally invasive approaches are being increasingly used. We compare our growing series of minimally invasive (combined thoracoscopic and laparoscopic) esophagectomies (MIEs) with a series of open transthoracic esophagectomies. Study Design: We identified 65 patients who underwent an MIE with thoracoscopy/laparotomy (n = 11), Ivor Lewis (n = 2), or 3-hole approach (n = 52). These patients were compared with 53 patients who underwent open Ivor-Lewis esophagectomy (n = 15) or 3-hole esophagectomy (n = 38) over the past 10 years. Results: The MIE and open groups were similar regarding gender and average age. The majority of patients in the open group underwent neoadjuvant chemoradiation therapy (81{\%}); a significantly smaller (43{\%}) number of patients in the MIE group underwent neoadjuvant therapy (p < 0.0001). Regarding oncologic efficacy, 97{\%} and 94{\%} of patients in both groups underwent R0 resections. Patients undergoing MIE had a significant increase in the number of harvested lymph nodes (median 20 vs 9; p < 0.0001). Length of stay was significantly decreased in patients who underwent MIE (8.5 days vs 16 days; p = 0.002). Finally, there were significantly fewer serious complications (grades 3-5) in the MIE group (19{\%} vs 48{\%}; p = 0.0008). Conclusions: In this initial report of a single-institution series of MIE, we demonstrate that oncologic efficacy is not compromised and may actually be improved with a significantly increased number of harvested LNs. We also demonstrate that this approach is associated with fewer serious complications and a significant decrease in the length of postoperative hospital stay.",
author = "Berger, {Adam C.} and Aaron Bloomenthal and Benny Weksler and Nathaniel Evans and Chojnacki, {Karen A.} and Yeo, {Charles J.} and Rosato, {Ernest L.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1016/j.jamcollsurg.2010.12.042",
language = "English (US)",
volume = "212",
pages = "560--566",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy

AU - Berger, Adam C.

AU - Bloomenthal, Aaron

AU - Weksler, Benny

AU - Evans, Nathaniel

AU - Chojnacki, Karen A.

AU - Yeo, Charles J.

AU - Rosato, Ernest L.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Background: Major morbidity and mortality rates continue to be high in large series of transthoracic esophagectomies. Minimally invasive approaches are being increasingly used. We compare our growing series of minimally invasive (combined thoracoscopic and laparoscopic) esophagectomies (MIEs) with a series of open transthoracic esophagectomies. Study Design: We identified 65 patients who underwent an MIE with thoracoscopy/laparotomy (n = 11), Ivor Lewis (n = 2), or 3-hole approach (n = 52). These patients were compared with 53 patients who underwent open Ivor-Lewis esophagectomy (n = 15) or 3-hole esophagectomy (n = 38) over the past 10 years. Results: The MIE and open groups were similar regarding gender and average age. The majority of patients in the open group underwent neoadjuvant chemoradiation therapy (81%); a significantly smaller (43%) number of patients in the MIE group underwent neoadjuvant therapy (p < 0.0001). Regarding oncologic efficacy, 97% and 94% of patients in both groups underwent R0 resections. Patients undergoing MIE had a significant increase in the number of harvested lymph nodes (median 20 vs 9; p < 0.0001). Length of stay was significantly decreased in patients who underwent MIE (8.5 days vs 16 days; p = 0.002). Finally, there were significantly fewer serious complications (grades 3-5) in the MIE group (19% vs 48%; p = 0.0008). Conclusions: In this initial report of a single-institution series of MIE, we demonstrate that oncologic efficacy is not compromised and may actually be improved with a significantly increased number of harvested LNs. We also demonstrate that this approach is associated with fewer serious complications and a significant decrease in the length of postoperative hospital stay.

AB - Background: Major morbidity and mortality rates continue to be high in large series of transthoracic esophagectomies. Minimally invasive approaches are being increasingly used. We compare our growing series of minimally invasive (combined thoracoscopic and laparoscopic) esophagectomies (MIEs) with a series of open transthoracic esophagectomies. Study Design: We identified 65 patients who underwent an MIE with thoracoscopy/laparotomy (n = 11), Ivor Lewis (n = 2), or 3-hole approach (n = 52). These patients were compared with 53 patients who underwent open Ivor-Lewis esophagectomy (n = 15) or 3-hole esophagectomy (n = 38) over the past 10 years. Results: The MIE and open groups were similar regarding gender and average age. The majority of patients in the open group underwent neoadjuvant chemoradiation therapy (81%); a significantly smaller (43%) number of patients in the MIE group underwent neoadjuvant therapy (p < 0.0001). Regarding oncologic efficacy, 97% and 94% of patients in both groups underwent R0 resections. Patients undergoing MIE had a significant increase in the number of harvested lymph nodes (median 20 vs 9; p < 0.0001). Length of stay was significantly decreased in patients who underwent MIE (8.5 days vs 16 days; p = 0.002). Finally, there were significantly fewer serious complications (grades 3-5) in the MIE group (19% vs 48%; p = 0.0008). Conclusions: In this initial report of a single-institution series of MIE, we demonstrate that oncologic efficacy is not compromised and may actually be improved with a significantly increased number of harvested LNs. We also demonstrate that this approach is associated with fewer serious complications and a significant decrease in the length of postoperative hospital stay.

UR - http://www.scopus.com/inward/record.url?scp=79953800749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953800749&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2010.12.042

DO - 10.1016/j.jamcollsurg.2010.12.042

M3 - Article

VL - 212

SP - 560

EP - 566

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 4

ER -